Metraipolis › archive › dc_bcb75b6bbc7d

A Five-Biomarker IHC-Based Signature Predicting Outcome in Breast Cancer Patients Following Adjuvant Anthracycline-Based Chemotherapy — Europe PMC PMID:41976315

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41976315
DOI
10.3390/cancers18071092
License (as archived)
solo-consultazione
Archived
2026-11-03T19:19:35.686Z
SHA-256 of the archived text
afe28adceec6fdacc3780109f9ebe1adcf32d5d4fc332e88b676a5d6c1e82db0
Stable URL of this page
https://metraipolis.com/documento/dc_bcb75b6bbc7d

How to cite

A Five-Biomarker IHC-Based Signature Predicting Outcome in Breast Cancer Patients Following Adjuvant Anthracycline-Based Chemotherapy — Europe PMC PMID:41976315 — Europe PMC (en), https://europepmc.org/article/MED/41976315 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bcb75b6bbc7d (Metraipolis archive dc_bcb75b6bbc7d, sha256 afe28adceec6fdacc3780109f9ebe1adcf32d5d4fc332e88b676a5d6c1e82db0)
BibTeX
@misc{dcbcb75b6bbc7d,
  title = {A Five-Biomarker IHC-Based Signature Predicting Outcome in Breast Cancer Patients Following Adjuvant Anthracycline-Based Chemotherapy — Europe PMC PMID:41976315},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41976315},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bcb75b6bbc7d; sha256 afe28adceec6fdacc3780109f9ebe1adcf32d5d4fc332e88b676a5d6c1e82db0},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41976315. Agents can read the archived copy with the MCP tool read_document.